首页> 外文OA文献 >Bringing Onco-Innovation to Europe’s Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine

【2h】

Bringing Onco-Innovation to Europe’s Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine

机译：为欧洲的医疗保健系统带来纽科 - 创新：生物标志物测试的潜力，现实世界的证据，肿瘤不可知的疗法，赋予个性化医学

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Denis Horgan; Gennaro Ciliberto; Pierfranco Conte; Giuseppe Curigliano; Luis Seijo; Luis M. Montuenga; Marina Garassino; Frederique Penault-Llorca; Fabrizia Galli; Isabelle Ray-Coquard; Denis Querleu; Peter Riegman; Keith Kerr; Hein Van Poppel; Anders Bjartell; Giovanni Codacci-Pisanelli; Jasmina Koeva-Balabanova; Angelo Paradiso; Zorana Maravic; Vassiliki Fotaki; Nuria Malats; Chiara Bernini; Simonetta Buglioni; Alastair Kent; Elisabetta Munzone; Ivica Belina; Jan Van Meerbeeck; Michael Duffy; Beata Jagielska; Ettore Capoluongo;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. Bringing Greater Accuracy to Europe’s Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology [J] . Horgan D., Ciliberto G., Conte P., Biomedicine hub. . 2020,第3期

机译：对欧洲的医疗保健系统带来更高的准确性：肿瘤学中的未开发的生物标志物测试潜力
2. Why BRCA mutations are not tumour-agnostic biomarkers for PARP inhibitor therapy [J] . Curtin Nicola J., Drew Yvette, Sharma-Saha Sweta Nature reviews. Clinical oncology . 2019,第12期

机译：为什么BRCA突变不是对PARP抑制剂治疗的肿瘤 - 无症式生物标志物
3. The Value of Diagnostic Information in Personalised Healthcare: A Comprehensive Concept to Facilitate Bringing This Technology into Healthcare Systems [J] . Wurcel Victoria, Cicchetti Americo, Garrison Louis, Public health genomics . 2019,第1a2期

机译：个性化医疗保健诊断信息的价值：综合概念，以促进将该技术赋予医疗保健系统
4. CONTROLLED RELEASE AND TUMOUR-TARGETED ANTI-TUMOUR MEDICINES: A REVIEW OF THE CURRENT USE AND FUTURE POTENTIAL IN CANCER CHEMOTHERAPY [C] . R. Duncan Proceedings of the 29th Annual Meeting of the Controlled Release Society . 2002

机译：控制释放和靶向肿瘤的抗肿瘤药物：癌症化疗的当前使用和未来潜力的回顾
5. Evaluation of the real-world injury-reduction potential of the proposed European pedestrian 'leg-form' impact test using a detailed finite element model of the lower limb. [D] . Schuster, Peter John. 2000

机译：使用详细的下肢有限元模型评估拟议中的欧洲行人“腿部形态”碰撞试验在现实世界中减少伤害的可能性。
6. Bringing Onco-Innovation to Europe’s Healthcare Systems: The Potential of Biomarker Testing Real World Evidence Tumour Agnostic Therapies to Empower Personalised Medicine [O] . Denis Horgan, Gennaro Ciliberto, Pierfranco Conte, 2021

机译：为欧洲的医疗保健系统带来纽科 - 创新：生物标志物测试的潜力现实世界的证据肿瘤不可知的疗法赋予个性化医学
7. Bringing onco-innovation to Europe’s healthcare systems: the unexploited potential of biomarker testing, real world evidence and the potential of Tumour Agnostics. The lesson from BRCA1/2 genetic testing [O] . Denis Horgan, Gennaro CILIBERTO, Pierfranco Conte, 2020

机译：为欧洲的医疗保健系统带来欧式创新：生物标志物检测的无法开发的潜力，现实世界的证据和肿瘤不合理的潜力。来自BRCA1 / 2遗传测试的课程

Bringing Onco-Innovation to Europe’s Healthcare Systems: The Potential of Biomarker Testing, Real World Evidence, Tumour Agnostic Therapies to Empower Personalised Medicine

著录项

引文网络

相似文献

相关主题

期刊订阅